Onc.AI, Inc.
Publicly observedSan Carlos, United States
Seen in a public record (e.g. a government grant database); not otherwise verified.
Details and provenance
| Item | Value | Source | Status |
|---|---|---|---|
| Country | US | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| City / locality | San Carlos | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| Name | Onc.AI, Inc. | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
| UEI (U.S. federal entity ID) | M79NZPAEXKS6 | NIH RePORTER (opens in a new tab) 28 Sept 2026 | Publicly observed |
Recorded events
- Grant5 Aug 2025Publicly observed
NIH SBIR/STTR award: Deep Learning Serial Radiomics for Improved Cancer Therapy Response Assessment.
USD 313,742.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant5 Aug 2025Publicly observed
NIH SBIR/STTR award: Deep Learning Serial Radiomics for Improved Cancer Therapy Response Assessment.
USD 1,686,258.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
- Grant13 Sept 2024Publicly observed
NIH SBIR/STTR award: Prospective validation of a radiomics-based multi-modal predictive model for metastatic non-small cell lung cancer patients treated with PD-1 immunotherapy
USD 375,000.00 · National Cancer Institute · Source: NIH RePORTER (opens in a new tab)
Information only — not investment advice or an endorsement. Is this your company? Submit or update its details or request a correction.